Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

@article{Nakano2012CombinedUO,
  title={Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.},
  author={Chikako Nakano and Takayuki Hamano and Naohiko Fujii and Isao Matsui and Kodo Tomida and Satoshi Mikami and Kazunori Inoue and Yoshitsugu Obi and Noriyuki Okada and Yoshiharu Tsubakihara and Yoshitaka Isaka and Hiromi Rakugi},
  journal={Clinical journal of the American Society of Nephrology : CJASN},
  year={2012},
  volume={7 5},
  pages={
          810-9
        }
}
BACKGROUND AND OBJECTIVES Hyperphosphatemia, vitamin D deficiency, hyperparathyroidism, and high serum fibroblast growth factor 23 (FGF23) levels, when studied separately, were found to predict the progression of CKD. However, studies with simultaneous measurement of mineral bone disorder (MBD)-related factors were scarce. This study aimed to identify factors predicting renal outcome independent of other factors. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS This was a prospective cohort… CONTINUE READING